North Carolina HB 736: Durham Auto Tax.
Status: Ch. SL 2003-329 (as of 2003-07-19)
State: North Carolina · Session: 2003 · Bill: HB 736
Subjects: COUNTIES, LOCAL, LOCAL GOVERNMENT, MOTOR VEHICLES, MUNICIPALITIES, PUBLIC, RATIFIED, TAXATION, TAXES, MOTOR VEHICLE, REP. MILLER, DURHAM COUNTY, DURHAM, CHAPTERED
Sponsors: Miller
Bill Text
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 H 1 HOUSE BILL 736 Short Title: Pharmacists/Test and Treat. (Public) Sponsors: Representative Huneycutt. For a complete list of sponsors, refer to the North Carolina General Assembly web site. Referred to: Health, if favorable, Appropriations, if favorable, Rules, Calendar, and Operations of the House April 3, 2025 *H736-v-1* A BILL TO BE ENTITLED 1 AN ACT TO ALLOW PHARMACISTS TO TEST AND TREAT FOR CERTAIN ILLNESSES 2 WITH CERTAIN MEDICATIONS APPROVED BY THE BOARD OF PHARMACY, TO 3 PROVIDE FOR FAIR AND EQUITABLE REIMBURSEMENT OF HEALTH CARE 4 SERVICES OR PROCEDURES THAT ARE PERFORMED BY A PHARMACIST 5 WITHIN THAT PHARMACIST'S SCOPE OF PRACTICE AND THAT ARE 6 EQUIVALENT TO SERVICES PERFORMED BY OTHER HEALTH CARE 7 PROFESSIONALS, AND TO APPROPRIATE FUNDS TO THE DEPARTMENT OF 8 INSURANCE. 9 The General Assembly of North Carolina enacts: 10 SECTION 1.(a) G.S. 90-85.3 reads as rewritten: 11 "§ 90-85.3. Definitions. 12 ... 13 (b2) "CLIA-waived test" means a laboratory test authorized by the Food and Drug 14 Administration and waived under the Clinical Laboratory Improvement Amendments of 1988. 15 (b3) "Clinical pharmacist practitioner" means a licensed pharmacist who meets the 16 guidelines and criteria for such title established by the joint subcommittee of the North Carolina 17 Medical Board and the North Carolina Board of Pharmacy and is authorized to enter into drug 18 therapy management agreements with physicians in accordance with the provisions of 19 G.S. 90-18.4. 20 ...." 21 SECTION 1.(b) G.S. 90-85.3A reads as rewritten: 22 "§ 90-85.3A. Practice of pharmacy. 23 ... 24 (b) A pharmacist may advise and educate patients and health care providers concerning 25 therapeutic values, content, uses, and significant problems of drugs and devices; assess, record, 26 and report adverse drug and device reactions; take and record patient histories relating to drug 27 and device therapy; administer drugs; monitor, record, and report drug therapy and device usage; 28 perform drug utilization reviews; and participate in drug and drug source selection and device 29 and device source selection as provided in G.S. 90-85.27 through G.S. 90-85.31. 30 ... 31 (e) A pharmacist may order and perform a CLIA-waived test to do any of the following: 32 (1) Assist with clinical decision making related to the use and monitoring of 33 medications. 34 General Assembly Of North Carolina Session 2025 Page 2 House Bill 736-First Edition (2) Treat influenza, COVID-19, pharyngitis caused by group A streptococcus, 1 and other health conditions screened by utilizing a CLIA-waived test, in 2 accordance with statewide protocols. A pharmacist shall not treat a health 3 condition under this section with any controlled substance classified in 4 Schedules I–IV." 5 SECTION 1.(c) This section becomes effective October 1, 2025. 6 SECTION 2.(a) Article 3 of Chapter 58 of the General Statutes is amended by adding 7 a new section to read: 8 "§ 58-3-241. Healthcare services provided by pharmacists. 9 (a) The following definitions apply in this section: 10 (1) Healthcare provider. – Either of the following: 11 a. An individual who is licensed, certified, or otherwise authorized under 12 Chapter 90 of the General Statutes to provide healthcare services in 13 the ordinary course of business or practice of a profession or in an 14 approved education or training program. 15 b. A health care facility licensed under Chapter 131E or Chapter 122C of 16 the General Statutes and where healthcare services are provided to 17 patients. 18 (2) Healthcare services. – Any of the following health or medical procedures or 19 services rendered by a healthcare provider: 20 a. Testing, diagnosis, or treatment of a health condition, illness, injury, 21 or disease. This includes testing, diagnosis, or treatment rendered by a 22 pharmacist acting within the pharmacist's scope of practice. 23 b. Dispensing of drugs, medical devices, medical appliances, or medical 24 goods for the treatment of a health condition, illness, injury, or disease. 25 c. Administration of a vaccine or medication. 26 (3) Pharmacist. – An individual licensed to practice pharmacy under Article 4A 27 of Chapter 90 of the General Statutes or the relevant laws of another state. 28 (b) A health benefit plan offered by an insurer in this State shall cover healthcare services 29 provided by a pharmacist if all of the following conditions are met: 30 (1) The service or procedure was performed within the pharmacist's licensed 31 lawful scope of practice. 32 (2) The health benefit plan would have covered the service if the service or 33 procedure had been performed by another healthcare provider. 34 (c) The participation of a pharmacy in a drug benefit provider network of a health benefit 35 plan shall not satisfy any requirement that insurers offering health benefit plans include 36 pharmacists in medical benefit provider networks." 37 SECTION 2.(b) G.S. 58-3-230 is ame
View North Carolina HB 736 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.